Preclinical Assessment of Simultaneous Targeting of Epidermal Growth Factor Receptor (ERBB1) and ERBB2 as a Strategy for Cholangiocarcinoma Therapy†,‡
Zichen Zhang(Henan University of Science and Technology), Alphonse E. Sirica(Virginia Commonwealth University)
Cited by 44
Related Papers
Intrahepatic Cholangiocarcinoma: Continuing Challenges and Translational Advances
|Hepatology|2018|340
Celecoxib-induced apoptosis in rat cholangiocarcinoma cells mediated by Akt inactivation and Bax translocation
|Hepatology|2004|120